Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-211 in Osteoarthritis of the Knee
NCT07550231Phase 2Not yet recruiting
- Sponsor
- Addpharma, Inc.
- Start
- Jun 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of celecoxib + eperisone in osteoarthritis (OA), sponsored by Addpharma, Inc.. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
celecoxib + eperisone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07550231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07550231.